Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma
Crossref DOI link: https://doi.org/10.1245/s10434-016-5702-5
Published Online: 2016-11-28
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fu, Hangcheng
Zhu, Yu
Wang, Yiwei
Liu, Zheng
Zhang, Junyu
Wang, Zewei
Xie, Huyang
Dai, Bo
Xu, Jiejie
Ye, Dingwei
License valid from 2016-11-28